Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

Melvin Deutsch(Zimmer Biomet (Netherlands)), David Pistenmaa(Memorial Sloan Kettering Cancer Center), Thomas A. Strike(Naval Medical Research Command), Michael Walker(Weizmann Institute of Science), Sylvan B. Green(Memorial Sloan Kettering Cancer Center), Joseph Ransohoff, John Mealey, Kenneth R. Smith(National Institutes of Health), Guy L. Odom, James T. Robertson, Peter C. Burger, William E. Hunt, Eben Alexander(Brigham and Women's Hospital), William R. Shapiro(National Institutes of Health), Robert G. Selker(Memorial Sloan Kettering Cancer Center), Byron Young(Charleston Area Medical Center), P. Paoletti
International Journal of Radiation Oncology*Biology*Physics
June 1, 1989
Cited by 179


Related Papers